Ophthalmology

Age-related macular degeneration (AMD) is the leading cause of vision loss and legal blindness for older adults in the United States. There is no cure, but with early intervention, treatment can slow the progression of the disease. It is crucial that primary eye care professionals, including ophthalmologists and optometrists, identify cases of AMD early to...

Low vision — poor eyesight that can’t be corrected by glasses, contact lenses, surgery or medication — afflicts more than 2 million Americans, according to the National Eye Institute (NEI). But this is a conservative estimate. Some 14 million Americans suffer from visual impairment if you include those with eye problems that hamper the performance...

Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the United States. As the population grows older, so does the increase in cases of age-related eye disease. Over 28 million American adults suffer from one or more eye-related diseases. Several populations are at a higher risk of developing these conditions....

Adaptive devices, including telescopic lenses, white canes, and guide dogs, have proven beneficial to those with chronic eye disease. The use of such adaptive devices can benefit those with age-related macular degeneration, diabetic retinopathy, glaucoma, and cataracts. Researchers sought to determine if and how many patients were utilizing these adaptive devices. They also sought to...

To develop drugs that are safe and effective in all populations, it is imperative that studies represent all racial/ethnic groups. Biological markers, socioeconomic barriers, and cultural differences are all critical factors in successful drug development. Clinical trials conducted between 2000 to 2020 played a vital role in the FDA approval of medications we currently use...

There has been a longstanding gender imbalance in the burden of disease affecting female patients with age-related macular degeneration (AMD). Researchers explored the trend patterns of this gender disparity over several decades to determine the extent of this imbalance in disease burden. Using data from the 2017 Global Burden of Disease Study, the researchers collected...

It is crucial that patients with age-related macular degeneration (AMD) are diagnosed early and receive continuous medical care. If not managed adequately, the outcome for patients with AMD is likely poor, and the disease may progress to wet AMD. Researchers sought to determine what socioeconomic barriers may be to blame for patients who are not...

Previous research has shown that wet and dry age-related macular degeneration (AMD) are most prevalent in Caucasian Americans. Asian Americans experience the next highest prevalence rates, followed by Hispanic Americans, and lastly, African Americans. The characteristics and progression of disease also vary based on patient race and ethnicity. Researchers sought to characterize the progression of...

Age-related macular degeneration (AMD) is becoming more prevalent due to the steady increase in human life expectancy. The visual impairment caused by this disease wreaks havoc on patient quality of life by limiting patient self-sufficiency. Thus, it is crucial to determine what factors contribute to disease progression and prevention. In this literature review, data were...